Medscape5d
Longer Acting GLP-1 Receptor Agonists and the Potential for Improved Cardiovascular Outcomes
GLP-1: Glucagon-like peptide-1; RA: receptor agonist. ACS: Acute coronary syndrome; CAD: Coronary artery disease; CHF: Congestive heart failure; CRF: Chronic renal ...
Hosted on MSN3d
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...
A new Ozempic rival helps patients lose fat, but keep their muscle — the holy grail for a weight-loss drug
The same antibody is also being tried with semaglutide ... In this case, it's boosting glucagon, a key blood-sugar-regulating ...
Medscape11d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
BBC2y
Protein structure and variety
Hormones are released from endocrine glands and are transported in the blood to target cells Insulin: released from pancreas, stimulates liver cells to take up glucose from the blood and Glucagon ...